These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Peripheral blood circulation in hemorrhagic shock and effects of various plasma substitutes]. Hara M Igaku Kenkyu; 1966 May; 36(3):305-20. PubMed ID: 6008561 [No Abstract] [Full Text] [Related]
25. Blood volume and plasma protein. V. Changes in blood volume and plasma proteins on administration of different substitutes after operations in man. Kaijser L; Rieger A Acta Chir Scand; 1968; 134(1):15-26. PubMed ID: 4876958 [No Abstract] [Full Text] [Related]
26. [Fundamentals in the therapy of hemorrhagic-traumatic shock conditions using plasma substitutes]. Lundsgaard-Hansen P Schweiz Med Wochenschr; 1968 Aug; 98(34):1273-81. PubMed ID: 5682776 [No Abstract] [Full Text] [Related]
27. [The effect of acute blood loss and its replacement by blood and blood substitutes on circulatory resistance in the vessels of the brain and heart]. Stoian EF Patol Fiziol Eksp Ter; 1971; 15(6):49-53. PubMed ID: 5146498 [No Abstract] [Full Text] [Related]
28. [Fundamentals in the therapy of hemorrhagic-traumatic shock conditions using plasms substitutes]. Lundsgaard-Hansen P Schweiz Med Wochenschr; 1968 Aug; 98(35):1320-5 concl. PubMed ID: 5682109 [No Abstract] [Full Text] [Related]
29. [Blood and colloidal plasma volume expanders. Blood circulation changes and differential indication]. Thimme W; Dissmann W; Eisele R Med Welt; 1970 Mar; 12():477-8 passim. PubMed ID: 5444235 [No Abstract] [Full Text] [Related]
30. [Experimental studies on the effectiveness of various volume expanding substances in the treatment of hemorrhagic shock]. Lutz H; Just OH Klin Med Osterr Z Wiss Prakt Med; 1967; 22(3):131-4. PubMed ID: 5632099 [No Abstract] [Full Text] [Related]
32. Evaluation of plasma substitutes in clinical shock; dextran. HAYNES BW; DE BAKEY ME Surg Forum; 1951; ():631-42. PubMed ID: 14931301 [No Abstract] [Full Text] [Related]
33. [Studies on the long-term treatment of experimental animals with plasma substitutes]. Lutz H; Peter K Bibl Haematol; 1971; 37():320-8. PubMed ID: 5138917 [No Abstract] [Full Text] [Related]
34. The metabolic response of the liver when acute experimental haemorrhagic shock is treated with dextran or gelatin-type plasma expanders. Hollmén A; Pihlajaniemi R; Reinilä M; Ryhänen P Ann Chir Gynaecol Fenn; 1972; 61(3):173-80. PubMed ID: 4639243 [No Abstract] [Full Text] [Related]
35. [The use of hemagel in hospital practice. Review and clinical report]. Jacobellis P; Vitelli M Minerva Chir; 1966 Jan; 21(1):31-6. PubMed ID: 5910989 [No Abstract] [Full Text] [Related]
36. [Influence of polyglucine, gelatinol and plasma on the redistribution of fluids in the organism of dogs following the replacement of blood losses]. Korolev VM Patol Fiziol Eksp Ter; 1976; (1):55-9. PubMed ID: 1272609 [No Abstract] [Full Text] [Related]
37. [Blood substitution by plasma expanders and the reactions in the blood coagulation system]. Pfeifer G Geburtshilfe Frauenheilkd; 1966 May; 26(5):720-4. PubMed ID: 5295914 [No Abstract] [Full Text] [Related]
38. Plasma substitutes past and present. Hässig A; Stampfli K Bibl Haematol; 1969; 33():1-8. PubMed ID: 4911197 [No Abstract] [Full Text] [Related]
39. [Animal experimental studies on the effect of colloidal plasma substitutes in canine hemorrhagic shock]. Lutz H Z Gesamte Exp Med Einschl Exp Chir; 1968 Apr; 146(4):383-96. PubMed ID: 5671891 [No Abstract] [Full Text] [Related]
40. [Oxygen regime of the body after replacement of acute blood loss with polyglucin in normo- and hyperoxic conditions]. Iarochkin VS; Volos OP; Turkevich NM Patol Fiziol Eksp Ter; 1985; (5):40-4. PubMed ID: 2415905 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]